Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model
出版年份 2018 全文链接
标题
Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 73, Issue 5, Pages 1330-1339
出版商
Oxford University Press (OUP)
发表日期
2018-01-20
DOI
10.1093/jac/dkx526
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- (2017) Andrew Rhodes et al. INTENSIVE CARE MEDICINE
- Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
- (2017) Sahand Imani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients
- (2016) Iris K. Minichmayr et al. CLINICAL PHARMACOKINETICS
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
- (2016) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsis
- (2016) Danny Tsai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU
- (2016) Stijn Jonckheere et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of carbapenems for the treatment ofPseudomonas aeruginosaventilator-associated pneumonia: associations with clinical outcome and recurrence
- (2016) Jared L. Crandon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem during the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
- (2015) Sutep Jaruratanasirikul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of dosing regimens and dosing in special populations
- (2015) F.B. Sime et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections
- (2015) Manjunath P. Pai et al. CLINICAL PHARMACOKINETICS
- Comparison of different equations to assess glomerular filtration in critically ill patients
- (2015) Mieke Carlier et al. INTENSIVE CARE MEDICINE
- Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria
- (2015) Matteo Bassetti et al. INTENSIVE CARE MEDICINE
- Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study
- (2015) Angela Huttner et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- TDMx: A novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routine
- (2015) Sebastian G. Wicha et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
- (2015) Mohd H. Abdul-Aziz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs
- (2015) Alexis Tabah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients
- (2015) Martin G. Kees et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial Pneumonia
- (2014) A. E. Muller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
- (2014) Jan J. De Waele et al. INTENSIVE CARE MEDICINE
- An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
- (2014) G. Wong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Stability of Generic Meropenem Solutions for Administration by Continuous Infusion at Normal and Elevated Temperatures
- (2014) Loretta Franceschi et al. THERAPEUTIC DRUG MONITORING
- Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
- (2014) João Goncalves-Pereira et al. BMC Pharmacology & Toxicology
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Can changes in renal function predict variations in β-lactam concentrations in septic patients?
- (2013) Giuseppe Stefano Casu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
- (2012) Federico Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
- (2012) J. M. Dulhunty et al. CLINICAL INFECTIOUS DISEASES
- Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients
- (2012) J. Cohen JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
- (2011) Andrew A. Udy et al. CHEST
- Optimization of meropenem dosage in the critically ill population based on renal function
- (2010) Jared L. Crandon et al. INTENSIVE CARE MEDICINE
- Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program—Asia-Pacific Region
- (2010) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Stability of meropenem and doripenem solutions for administration by continuous infusion
- (2010) K. Berthoin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of meropenem in burn patients
- (2010) K. Doh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
- (2009) Jason A. Roberts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Simple and Fast Method for Quantification of Ertapenem using Meropenem as Internal Standard in Human Plasma in a Clinical Setting
- (2009) Antonio DʼAvolio et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetic and Pharmacodynamic Properties of Meropenem
- (2008) David P. Nicolau CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started